QLT reports interim phase Ib data on QLT-091001 in Leber's congenital amaurosis April 21, 2010 No Comments
First phase III trial of ThromboGenics' microplasmin for eye disease meets primary endpoint April 21, 2010 No Comments
Phase II trial of ranibizumab in diabetic macular edema commences enrollment April 8, 2010 No Comments
Asahi Kasei grants Altheos exclusive rights to AK-138 series compounds for glaucoma April 7, 2010 No Comments
Single- and repeat-dose studies encourage further evaluation of ACU-4429 in AMD March 31, 2010 No Comments
RSS